Ethic Inc’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.31M | Buy |
75,093
+3,821
| +5% | +$423K | 0.15% | 146 |
|
2025
Q1 | $7.93M | Sell |
71,272
-33,372
| -32% | -$3.71M | 0.16% | 134 |
|
2024
Q4 | $9.67M | Buy |
104,644
+7,638
| +8% | +$706K | 0.2% | 100 |
|
2024
Q3 | $7.11M | Buy |
97,006
+7,482
| +8% | +$548K | 0.18% | 120 |
|
2024
Q2 | $6.14M | Sell |
89,524
-7,482
| -8% | -$513K | 0.14% | 149 |
|
2024
Q1 | $7.11M | Sell |
97,006
-15,772
| -14% | -$1.16M | 0.18% | 120 |
|
2023
Q4 | $9.14M | Buy |
112,778
+4,423
| +4% | +$358K | 0.27% | 74 |
|
2023
Q3 | $8.12M | Buy |
108,355
+7,508
| +7% | +$563K | 0.28% | 72 |
|
2023
Q2 | $7.77M | Buy |
100,847
+5,808
| +6% | +$448K | 0.29% | 71 |
|
2023
Q1 | $7.89M | Buy |
95,039
+31,117
| +49% | +$2.58M | 0.32% | 62 |
|
2022
Q4 | $5.49M | Buy |
63,922
+19,028
| +42% | +$1.63M | 0.3% | 77 |
|
2022
Q3 | $2.77M | Buy |
44,894
+13,979
| +45% | +$862K | 0.19% | 133 |
|
2022
Q2 | $1.91M | Buy |
30,915
+3,895
| +14% | +$241K | 0.13% | 200 |
|
2022
Q1 | $1.61M | Sell |
27,020
-3,626
| -12% | -$216K | 0.11% | 240 |
|
2021
Q4 | $2.23M | Sell |
30,646
-12,477
| -29% | -$906K | 0.17% | 145 |
|
2021
Q3 | $3.01M | Sell |
43,123
-6,690
| -13% | -$467K | 0.31% | 75 |
|
2021
Q2 | $3.43M | Buy |
49,813
+15,969
| +47% | +$1.1M | 0.42% | 48 |
|
2021
Q1 | $2.19M | Buy |
33,844
+14,567
| +76% | +$941K | 0.39% | 53 |
|
2020
Q4 | $1.12M | Buy |
19,277
+4,419
| +30% | +$257K | 0.3% | 82 |
|
2020
Q3 | $939K | Buy |
14,858
+3,772
| +34% | +$238K | 0.36% | 63 |
|
2020
Q2 | $853K | Buy |
11,086
+1,446
| +15% | +$111K | 0.49% | 46 |
|
2020
Q1 | $721K | Buy |
9,640
+1,878
| +24% | +$140K | 0.6% | 46 |
|
2019
Q4 | $504K | Buy |
+7,762
| New | +$504K | 0.37% | 89 |
|